Last reviewed · How we verify

NCT06862076

Impact of Lung Function Prehabilitation to Postoperative Pulmonary Complications

Completed NA Last updated 6 March 2025
What this trial tests

NA trial testing Lung Function Prehabilitation in Postoperative Pulmonary Complications (PPCs) in 40 participants. Completed in 12 November 2024.

Timeline
1 August 2023
Primary endpoint
30 June 2024
12 November 2024

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment40
Start date1 August 2023
Primary completion30 June 2024
Estimated completion12 November 2024
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

18 and older, any sex, with Postoperative Pulmonary Complications (PPCs). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effect of lung function prehabilitation to postoperative pulmonary complications on patient undergoing upper abdominal surgery treated in intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Pulmonary Complications (PPCs)

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06862076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing